11-16-2020, 10:18 AM
Some additional good news:
Also:
They didn't discuss how many of those cases occurred in the treated group to allow us to estimate efficacy in these groups. With 15 events in older volunteers and 20 in non-White participants, you won't have a ton of precision, but it should allow you to estimate if it is more than 50% effective.
BC
Quote:A secondary endpoint analyzed severe cases of COVID-19 and included 11 severe cases (as defined in the study protocol) in this first interim analysis. All 11 cases occurred in the placebo group and none in the mRNA-1273 vaccinated group.
Also:
Quote:The 95 COVID-19 cases included 15 older adults (ages 65+) and 20 participants identifying as being from diverse communities (including 12 Hispanic or LatinX, 4 Black or African Americans, 3 Asian Americans and 1 multiracial).
They didn't discuss how many of those cases occurred in the treated group to allow us to estimate efficacy in these groups. With 15 events in older volunteers and 20 in non-White participants, you won't have a ton of precision, but it should allow you to estimate if it is more than 50% effective.
BC